Neuromyelitis optica spectrum disorder presenting with myoclonus and brainstem involvement: an atypical initial manifestation
Abstract
Case Presentation: A 27-year-old woman presented with a subacute neurological syndrome initially characterized by myoclonic jerks in the upper limbs. Over the following days, she developed blurred vision in the left eye and horizontal diplopia secondary to left abducens nerve (VI cranial nerve) palsy. Her symptoms progressed to include bilateral upper limb tremor and ataxia involving all four limbs. Neurological examination confirmed left sixth nerve palsy, appendicular tremor, and generalized limb ataxia. Brain and spinal cord magnetic resonance imaging (MRI) revealed demyelinating lesions affecting the brainstem, bilateral middle cerebellar peduncles, and the cervical and thoracic spinal cord. Cerebrospinal fluid analysis showed elevated protein levels without evidence of infection. Based on the lesion distribution and clinical presentation, a demyelinating inflammatory disorder was suspected. The patient received high-dose intravenous methylprednisolone pulse therapy, with significant clinical improvement. Long-term immunotherapy was subsequently initiated. Overall, the clinical, radiological, and laboratory findings supported a diagnosis of neuromyelitis optica spectrum disorder (NMOSD), presenting atypically with myoclonus and prominent brainstem involvement. Discussion: NMOSD is an autoimmune demyelinating disease predominantly affecting females aged 30-40. The primary target is aquaporin-4 on astrocytes, and antibody-mediated injury leads to astrocyte dysfunction, secondary oligodendrocyte and axonal damage, and perivascular demyelination. Typical manifestations include optic neuritis, with blurred vision, decreased visual acuity, and ocular pain, and transverse myelitis, causing variable sensorimotor deficits in all four limbs, often with bowel or bladder involvement. Atypical presentations, such as myoclonus or prominent brainstem and cerebellar symptoms, are uncommon and can delay diagnosis. Brainstem lesions may produce cranial nerve palsies, ataxia, tremor, and ocular motor disturbances, as observed in this case. Early recognition is crucial, as delayed diagnosis may postpone immunotherapy and increase the risk of permanent deficits. MRI findings, particularly demyelinating lesions in the brainstem and middle cerebellar peduncles, combined with cerebrospinal fluid analysis, are critical for accurate diagnosis and differentiation from other demyelinating or infectious processes. High-dose intravenous corticosteroid therapy remains the first-line acute treatment, often yielding substantial improvement. Long-term immunotherapy reduces relapse risk and prevents disease progression. Final Comments: This case highlights that NMOSD can present with atypical, subacute neurological syndromes, including brainstem manifestations such as myoclonus, tremor, and cranial nerve palsies. Early recognition and prompt immunotherapy are essential to improve outcomes, reduce relapse-related morbidity, and achieve favorable long-term prognosis.